Immunic, Inc.(IMUX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMUX Immunic, Inc.

未开盘 05-17 16:00:00 EDT

1.25

+0.00

-0.40%

盘后1.22

-0.02-1.95%

19:57 EDT

最高1.26	最低1.18	成交量141.14万
今开1.23	昨收1.25	日振幅6.40%
总市值1.12亿	流通市值6,650万	总股本9,008万
成交额170.56万	换手率2.64%	流通股本5,341万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMUX","market":"US","secType":"STK","nameCN":"Immunic, Inc.","latestPrice":1.245,"timestamp":1715976000000,"preClose":1.25,"halted":0,"volume":1411370,"hourTrading":{"tag":"盘后","latestPrice":1.2207,"preClose":1.245,"latestTime":"19:57 EDT","volume":19823,"amount":24706.4002,"timestamp":1715990243795},"delay":0,"floatShares":53414235,"shares":90079016,"eps":-1.696275,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.005,"latestTime":"05-17 16:00:00 EDT","open":1.23,"high":1.26,"low":1.18,"amount":1705571.3467330001,"amplitude":0.064,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.696275,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1397707200000,"adjPreClose":1.25,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.24,"preClose":1.25,"latestTime":"09:29 EDT","volume":861,"amount":1082.9032053,"timestamp":1715952599114},"postHourTrading":{"tag":"盘后","latestPrice":1.2207,"preClose":1.245,"latestTime":"19:57 EDT","volume":19823,"amount":24706.4002,"timestamp":1715990243795},"volumeRatio":8.61416112606743},"requestUrl":"/m/hq/s/IMUX/tweets","defaultTab":"tweets","newsList":[{"id":"2436078736","title":"Immunic, Inc.2024财年第一财季实现净利润-29.58百万美元，同比减少17.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436078736","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2436078736?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:20","pubTimestamp":1715876434,"startTime":"0","endTime":"0","summary":"3月31日，Immunic, Inc.公布财报，公告显示公司2024财年第一财季净利润为-29.58百万美元，同比减少17.06%；其中营业收入为0.00美元，每股基本收益为-0.30美元。从资产负债表来看，Immunic, Inc.总负债20.58百万美元，其中短期债务697000.00美元，资产负债比为0.06，流动比率为0.06。机构评级：截至2024年3月31日，当前有5家机构对Immunic, Inc.目标价做出预测，其中目标均价为11.50美元，其中最低目标价为4.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170020398b0f8b7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170020398b0f8b7f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433729648","title":"Immunic, Inc.盘中异动 快速下挫5.36%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433729648","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433729648?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:31","pubTimestamp":1715175111,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时31分，Immunic, Inc.股票出现波动，股价大幅下跌5.36%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821315287e09621&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821315287e09621&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433405756","title":"Immunic Inc    预计每股亏损 26 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433405756","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433405756?lang=zh_cn&edition=full","pubTime":"2024-05-06 23:33","pubTimestamp":1715009595,"startTime":"0","endTime":"0","summary":"   * Immunic公司   将于5月8日公布截至2024年3月31日的财报，预计季度收入将保持不变。*    * LSEG的分析师平均预计Immunic Inc每股亏损26美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 4 个 \"强烈买入 \"或 \"买入\"，1 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Immunic Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 1.37 美元。5月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429119145","title":"Immunic, Inc.盘中异动 早盘大幅拉升6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429119145","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429119145?lang=zh_cn&edition=full","pubTime":"2024-04-23 23:12","pubTimestamp":1713885175,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日23时12分，Immunic, Inc.股票出现波动，股价快速上涨6.50%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为1.57%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423231255861e836f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423231255861e836f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429905231","title":"Immunic, Inc.盘中异动 急速上涨5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429905231","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429905231?lang=zh_cn&edition=full","pubTime":"2024-04-23 03:41","pubTimestamp":1713814871,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日03时41分，Immunic, Inc.股票出现异动，股价急速拉升5.08%。截至发稿，该股报1.24美元/股，成交量14.1747万股，换手率0.16%，振幅5.51%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042303411187e82936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042303411187e82936&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428660260","title":"Immunic, Inc.盘中异动 下午盘急速下挫5.26%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428660260","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428660260?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:30","pubTimestamp":1713551414,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时30分，Immunic, Inc.股票出现异动，股价大幅跳水5.26%。截至发稿，该股报1.20美元/股，成交量19.5401万股，换手率0.22%，振幅7.87%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Immunic, Inc.公司简介：Immunic Inc 是一家临床阶段生物制药公司，正在开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎，克罗恩病，复发性多发性硬化症和银屑病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200230147a54286b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200230147a54286b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428515247","title":"Immunic, Inc.盘中异动 早盘快速上涨5.79%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428515247","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428515247?lang=zh_cn&edition=full","pubTime":"2024-04-18 23:07","pubTimestamp":1713452821,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日23时07分，Immunic, Inc.股票出现异动，股价急速拉升5.79%。截至发稿，该股报1.28美元/股，成交量7.5567万股，换手率0.08%，振幅5.79%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Immunic, Inc.公司简介：Immunic Inc是一家临床阶段的生物制药公司，开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎、克罗恩病、复发缓解型多发性硬化症和牛皮癣。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041823070287e81c62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041823070287e81c62&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428321905","title":"Immunic, Inc.盘中异动 下午盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428321905","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428321905?lang=zh_cn&edition=full","pubTime":"2024-04-18 01:14","pubTimestamp":1713374076,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日01时14分，Immunic, Inc.股票出现异动，股价快速下跌5.47%。截至发稿，该股报1.21美元/股，成交量8.2133万股，换手率0.09%，振幅5.47%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Immunic, Inc.公司简介：Immunic Inc是一家临床阶段的生物制药公司，开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎、克罗恩病、复发缓解型多发性硬化症和牛皮癣。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418011436861e6c34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418011436861e6c34&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428809210","title":"Immunic, Inc.盘中异动 股价大跌5.34%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428809210","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428809210?lang=zh_cn&edition=full","pubTime":"2024-04-17 02:30","pubTimestamp":1713292259,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日02时30分，Immunic, Inc.股票出现波动，股价急速下跌5.34%。截至发稿，该股报1.24美元/股，成交量9.7002万股，换手率0.11%，振幅6.10%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Immunic, Inc.公司简介：Immunic Inc是一家临床阶段的生物制药公司，开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎、克罗恩病、复发缓解型多发性硬化症和牛皮癣。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417023100861e65e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417023100861e65e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427004637","title":"Immunic, Inc.盘中异动 早盘急速下跌6.25%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427004637","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427004637?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:29","pubTimestamp":1713191353,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时29分，Immunic, Inc.股票出现异动，股价急速跳水6.25%。截至发稿，该股报1.35美元/股，成交量9.6703万股，换手率0.11%，振幅4.16%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Immunic, Inc.公司简介：Immunic Inc是一家临床阶段的生物制药公司，开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎、克罗恩病、复发缓解型多发性硬化症和牛皮癣。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415222914861e5d3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415222914861e5d3d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425565743","title":"Immunic, Inc.盘中异动 股价大涨5.69%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425565743","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425565743?lang=zh_cn&edition=full","pubTime":"2024-04-05 21:33","pubTimestamp":1712323983,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日21时33分，Immunic, Inc.股票出现异动，股价快速拉升5.69%。截至发稿，该股报1.30美元/股，成交量9.8922万股，换手率0.11%，振幅3.20%。Immunic, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Immunic, Inc.公司简介：Immunic Inc是一家临床阶段的生物制药公司，开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎、克罗恩病、复发缓解型多发性硬化症和牛皮癣。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052133038af4358f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404052133038af4358f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421770348","title":"Immunic, Inc.盘中异动 快速上涨5.30%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421770348","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421770348?lang=zh_cn&edition=full","pubTime":"2024-03-21 03:54","pubTimestamp":1710964456,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日03时54分，Immunic, Inc.股票出现异动，股价快速上涨5.30%。截至发稿，该股报1.39美元/股，成交量19.8093万股，换手率0.22%，振幅5.68%。Immunic, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Immunic, Inc.公司简介：Immunic Inc是一家临床阶段的生物制药公司，开发一系列选择性口服免疫疗法，旨在治疗慢性炎症和自身免疫性疾病，包括溃疡性结肠炎、克罗恩病、复发缓解型多发性硬化症和牛皮癣。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321035416861dfd64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321035416861dfd64&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.imux.com","stockEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0289},{"period":"3month","weight":-0.0119},{"period":"6month","weight":0.1745},{"period":"1year","weight":-0.2966},{"period":"ytd","weight":-0.17}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunic, Inc.通过收购VitaGen公司的资产和业务，作为一个加利福尼亚州的公司于2003年5月23日开始运营，并于2003年6月更名为Vital生命治疗有限公司。2004年1月，公司再次在特拉华州注册成立。公司是一家生物治疗公司，致力于开发基于细胞的急性肝功能衰竭的治疗。候选产品目前在三期临床试验中，ELAD系统（或ELAD）是一个体外生物人工肝治疗，目的是在病人移植之前让病人自己的肝脏再生一个健康的状态或稳定的肝脏。自成立以来，它已经基本上倾注了全部的努力至产品开发、临床试验和试生产，还没有意识到收入来自计划主营业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.058839},{"month":2,"riseRate":0.3,"avgChangeRate":-0.011826},{"month":3,"riseRate":0.3,"avgChangeRate":-0.04127},{"month":4,"riseRate":0.3,"avgChangeRate":0.053504},{"month":5,"riseRate":0.1,"avgChangeRate":-0.071481},{"month":6,"riseRate":0.6,"avgChangeRate":0.166186},{"month":7,"riseRate":0.5,"avgChangeRate":0.001487},{"month":8,"riseRate":0.6,"avgChangeRate":-0.043344},{"month":9,"riseRate":0.4,"avgChangeRate":-0.104933},{"month":10,"riseRate":0.4,"avgChangeRate":-0.004052},{"month":11,"riseRate":0.5,"avgChangeRate":0.00409},{"month":12,"riseRate":0.7,"avgChangeRate":0.069641}],"exchange":"NASDAQ","name":"Immunic, Inc.","nameEN":"Immunic, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunic, Inc.(IMUX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunic, Inc.(IMUX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunic, Inc.,IMUX,Immunic, Inc.股票,Immunic, Inc.股票老虎,Immunic, Inc.股票老虎国际,Immunic, Inc.行情,Immunic, Inc.股票行情,Immunic, Inc.股价,Immunic, Inc.股市,Immunic, Inc.股票价格,Immunic, Inc.股票交易,Immunic, Inc.股票购买,Immunic, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunic, Inc.(IMUX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunic, Inc.(IMUX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}